GB202008288D0 - Methods and compositions for treating and combatting sars-cov and sars-cov-2 - Google Patents
Methods and compositions for treating and combatting sars-cov and sars-cov-2Info
- Publication number
- GB202008288D0 GB202008288D0 GBGB2008288.9A GB202008288A GB202008288D0 GB 202008288 D0 GB202008288 D0 GB 202008288D0 GB 202008288 A GB202008288 A GB 202008288A GB 202008288 D0 GB202008288 D0 GB 202008288D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- cov
- sars
- combatting
- compositions
- treating
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
Priority Applications (10)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2008288.9A GB202008288D0 (en) | 2020-06-02 | 2020-06-02 | Methods and compositions for treating and combatting sars-cov and sars-cov-2 |
JP2022564201A JP2023526584A (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 |
US17/920,123 US20240016831A1 (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
CN202180044441.XA CN115884758A (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide-releasing compositions for the treatment of SARS-CoV and SARS-CoV-2 |
GB2217440.3A GB2610722B (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating SARS-COV and SARS-COV-2 |
CA3180857A CA3180857A1 (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
AU2021259360A AU2021259360A1 (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating SARS-CoV and SARS-CoV-2 |
PCT/GB2021/050935 WO2021214440A1 (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
EP21722534.1A EP4138795A1 (en) | 2020-04-23 | 2021-04-19 | Nitric oxide or nitric oxide releasing compositions for use in treating sars-cov and sars-cov-2 |
BR112022021454A BR112022021454A2 (en) | 2020-04-23 | 2021-04-19 | NITRIC OXIDE OR NITRIC OXIDE-RELEASING COMPOSITIONS FOR USE IN THE TREATMENT OF SARS-COV AND SARS-COV-2 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB2008288.9A GB202008288D0 (en) | 2020-06-02 | 2020-06-02 | Methods and compositions for treating and combatting sars-cov and sars-cov-2 |
Publications (1)
Publication Number | Publication Date |
---|---|
GB202008288D0 true GB202008288D0 (en) | 2020-07-15 |
Family
ID=71526183
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GBGB2008288.9A Ceased GB202008288D0 (en) | 2020-04-23 | 2020-06-02 | Methods and compositions for treating and combatting sars-cov and sars-cov-2 |
Country Status (1)
Country | Link |
---|---|
GB (1) | GB202008288D0 (en) |
-
2020
- 2020-06-02 GB GBGB2008288.9A patent/GB202008288D0/en not_active Ceased
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP4097122A4 (en) | Compositions and methods for preventing and treating coronavirus infection-sars-cov-2 vaccines | |
ZA202207394B (en) | Compositions and methods for treating hemoglobinopathies | |
GB2610721B (en) | Compositions for treating and combatting tuberculosis | |
EP4136254A4 (en) | Ace2-targeted compositions and methods for treating covid-19 | |
EP4178575A4 (en) | Compositions and methods for inhibiting and treating coronavirus infections | |
IL285886A (en) | Compositions and methods for treating laminopathies | |
IL308221A (en) | Compositions and methods for the treatment of depression | |
EP4199950A4 (en) | Methods and compositions for treating coronavirus infections | |
IL277315B (en) | Methods and composition for treating coronavirus infection | |
IL285796A (en) | Methods and compositions for treating | |
EP4171606A4 (en) | Compositions and methods for the treatment of covid-19 | |
ZA202206163B (en) | Methods of treating coronavirus | |
EP4178586A4 (en) | Compositions and methods for inhibiting ythdf1 | |
IL304273A (en) | Compositions and methods for treating fabry disease | |
EP4232160A4 (en) | Compositions and methods for preventing and treating coronaviruses | |
IL307872A (en) | Novel compositions and methods for treating coronavirus infections | |
GB202008288D0 (en) | Methods and compositions for treating and combatting sars-cov and sars-cov-2 | |
GB202005987D0 (en) | Methods and compositions for treating and combatting sars-cov and sars-cov-2 | |
EP4151216A4 (en) | Compound for treating and/or preventing diseases caused by coronavirus and use thereof | |
EP4203929A4 (en) | Methods and compositions for treating heart conditions | |
EP4009981C0 (en) | Method and compositions for treating coronavirus infection | |
GB202005986D0 (en) | Methods and compositions for treating and combatting tuberulosis | |
EP3946302A4 (en) | Methods and compositions for treating pain | |
IL314497A (en) | Compositions and methods for covid-19 treatment | |
GB202008285D0 (en) | Methods and compositions for treating and combatting tuberculosis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AT | Applications terminated before publication under section 16(1) |